Yazar "Yağız, B." için Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed listeleme
-
BIOLOGIC DRUG PREFERENCES OF TURKISH RHEUMATOLOGISTS IN SPONDILOARTROPATHY PATIENTS WITH ADVANCED CHRONIC RENAL DISEASE
Mercan, Rıdvan; Tezcan, M. E.; Yağız, B.; Ateş, A.; Küçükşahin, O.; Bilge, N. S. Yaşar; Kanitez, N. A. (Bmj Publishing Group, 2022)[Abstract Not Available] -
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
Kimyon, G.; Kalyoncu, U.; Kiraz, S.; Beş, C.; Coşkun, N.; Yağız, B.; Ertenli, I; Mercan, Rıdvan (Clinical & Exper Rheumatology, 2021)Objective To determine the real-life efficacy, safety, and drug-retention rates of leflunomide (LEF) or methotrexate (MTX) as a synthetic DMARD used in combination with biological DMARDs for rheumatoid arthritis (RA). ... -
THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA
Gönüllü, E.; Kalyoncu, U.; Yağız, B.; Ateş, A.; Küçükşahin, O.; Bilge, N. S. Yaşar; Kanitez, N. A.; Mercan, Rıdvan (Bmj Publishing Group, 2022)[Abstract Not Available] -
EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS IN PATIENTS WITH RHEUMATIC DISEASES - IMPLICATIONS FROM TREASURE DATABASE
Ersözlu, D.; Ekici, M.; Coşkun, B. N.; Badak, S. O.; Bilgin, E.; Kalyoncu, U.; Yağız, B.; Mercan, Rıdvan (Bmj Publishing Group, 2022)[Abstract Not Available] -
PARADOXICAL REACTIONS, ESPECIALLY PSORIASIS IN RHEUMATOLOGY PATIENTS RECEIVING BIOLOGIC THERAPY FROM THE TREASURE DATABASE: A 5-YEAR FOLLOW-UP STUDY
Yağız, B.; Lermi, N.; Coşkun, B. N.; Dalkılıç, E.; Kiraz, S.; Ertenli, A. I.; Bilgin, E.; Mercan, Rıdvan (Bmj Publishing Group, 2022)[Abstract Not Available]